Endocrine Abstracts

Since the emergence of the Covid-19 pandemic in 2019, a massive vaccination campaign has been undertaken around the world, and SARS-CoV-2 vaccines-induced thyroid diseases became more frequently described in the literature. Subacute thyroiditis is reported in 52 patients, mean age 45.5±1.8 years, mainly in women (n = 39), after the first (62%) or the second (38%) dose of mRNA (60%), inactivated whole-virus (25%) and adenoviral-vectored (13.5%) vaccines. The mean ti...

Introduction: The information on prognosis morbidity chronic autoimmune thyroiditis and relationship with coronavirus disease 2019 (COVID-19) is lacking but endocrine involvement has been increasingly reported. The symptoms of thyroid’s dysfunction can be due to relationship after SARS-CoV-2 infection. In addition, the patients with COVID-19 leading to an increased risk of post COVID-19 complications of chronic autoimmune thyroiditis. As such, post COVID-19 complications ...

Objectives: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is causing coronavirus disease (COVID-19), enters host cells via the angiotensin-converting enzyme 2 receptor. Its expression is higher in thyroid gland than in lungs. In the literature, an association between SARS-CoV-2 infection and subacute thyroiditis/autoimmune thyroid disease has been implicated. Therefore, we aimed to explore the influence of COVID-19 pandemic on the incidence of subacute th...

Subacute thyroiditis (SAT) is an inflammation of the thyroid gland characterized by varying degrees of severity regarding thyrotoxicosis, inflammation and the incidence of hypothyroidism. The present study aims to identify whether the severity of SAT depends on the causative agent involved and to identify what is the optimal therapy. To this purpose we retrospectively evaluated 402 patients referred to of the University Hospital of Pisa because of to a SAT from January 2011 to...

Aim: The aim of this study is to find out whether Subacute Thyroiditis may occur after Covid -19 Vaccination.Materials and methods: This investigation was designed and held in “Kanaker-Zeytun” Medical Center and “Muratsan” University Hospital. 25 women (age: 35±7) with proved diagnoses of Subacute Thyroiditis were included in the study. The detailed history of disease was collected in order to understand how many of them survived C...

The Purpose of The Research: The aim of the study is to reveal whether there are any peculiarities of treatment of the subacute thyroiditis, which was caused by Covid-19.Materials and Methods: The research has been conducted in “Muratsan” Hospital Complex and Armenian-American Wellness Center during 2020-2021. Among forty five patients who participated in the study were women about 35+10 years old and all of them were diagnosed with subacute th...

Background: Subacute thyroiditis (SAT) is a destructive thyroiditis which is presumably caused by a viral infections or post-viral inflammatory response. Thyroid dysfunction evolves through a set of stages (hyperthyroidism - hypothyroidism - euthyroidism) and is usually temporary, although some patients may develop permanent hypothyroidism. The risk factors for permanent hypothyroidism remain unclear.Methods: A retrospective analysis of patients with SAT...

Background: The Covid-19 pandemic caused by the severe-acute-respiratory-syndrome-coronavirus-2 (SARS-CoV-2) determined millions of deaths worldwide, thus at the end of 2020 a massive vaccination campaign has been launched. SARS-CoV-2 infection and vaccines have been associated with several thyroid disorders, especially subacute thyroiditis (SAT), Graves’ disease (GD) and orbitopathy (GO). We studied the occurrence of SAT and GO following SARS-CoV-2 infection or vaccinati...

Introduction: Subacute thyroiditis (SAT) is an inflammatory disorder of thyroid associated with viral infections. Rarely, cases of SAT have also been described post-vaccination, but there are not many reports related to exposure to the COVID-19 vaccine. Here, we present a case of subacute thyroiditis after receiving the first dose of a SARS-CoV-2 vaccination inactivated COVID-19 vaccine (Sinovac-CoronaVac, developed by Sinovac/China National Pharmaceutical Group).<p class=...